Reuters logo
Reckitt Benckiser has not decided whether to keep pharma stake
July 28, 2014 / 7:06 AM / 3 years ago

Reckitt Benckiser has not decided whether to keep pharma stake

LONDON, July 28 (Reuters) - Reckitt Benckiser Group has not decided whether to maintain a stake in its shrinking pharmaceuticals business following a spin-off it expects to complete in the next 12 months.

Even though Reckitt is preparing for a spin, it could still end up selling it along the way, its chief financial officer said on Monday.

If the planned spin-off is completed, Shaun Thaxter will be the company’s chief executive, and Howard Pien will be its chairman, Reckitt said.

Reporting by Martinne Geller in London

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below